These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20704485)

  • 21. Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03).
    Le Clerc S; Limou S; Coulonges C; Carpentier W; Dina C; Taing L; Delaneau O; Labib T; Sladek R; ; Deveau C; Guillemain H; Ratsimandresy R; Montes M; Spadoni JL; Therwath A; Schächter F; Matsuda F; Gut I; Lelièvre JD; Lévy Y; Froguel P; Delfraissy JF; Hercberg S; Zagury JF
    J Infect Dis; 2009 Oct; 200(8):1194-201. PubMed ID: 19754311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
    Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS;
    AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR2 chemokine receptor and AIDS progression.
    Smith MW; Carrington M; Winkler C; Lomb D; Dean M; Huttley G; O'Brien SJ
    Nat Med; 1997 Oct; 3(10):1052-3. PubMed ID: 9334699
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
    Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
    Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).
    McDermott DH; Zimmerman PA; Guignard F; Kleeberger CA; Leitman SF; Murphy PM
    Lancet; 1998 Sep; 352(9131):866-70. PubMed ID: 9742978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Insights into the Disease Progression Control Mechanisms by Comparing Long-Term-Nonprogressors versus Normal-Progressors among HIV-1-Positive Patients Using an Ion Current-Based MS1 Proteomic Profiling.
    Shen X; Nair B; Mahajan SD; Jiang X; Li J; Shen S; Tu C; Hsiao CB; Schwartz SA; Qu J
    J Proteome Res; 2015 Dec; 14(12):5225-39. PubMed ID: 26484939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.
    Wetzel KS; Yi Y; Elliott STC; Romero D; Jacquelin B; Hahn BH; Muller-Trutwin M; Apetrei C; Pandrea I; Collman RG
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
    Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
    J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole Exome Sequencing of HIV-1 long-term non-progressors identifies rare variants in genes encoding innate immune sensors and signaling molecules.
    Nissen SK; Christiansen M; Helleberg M; Kjær K; Jørgensen SE; Gerstoft J; Katzenstein TL; Benfield T; Kronborg G; Larsen CS; Laursen A; Pedersen G; Jakobsen MR; Tolstrup M; Mogensen TH
    Sci Rep; 2018 Oct; 8(1):15253. PubMed ID: 30323326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS.
    Herbeck JT; Gottlieb GS; Winkler CA; Nelson GW; An P; Maust BS; Wong KG; Troyer JL; Goedert JJ; Kessing BD; Detels R; Wolinsky SM; Martinson J; Buchbinder S; Kirk GD; Jacobson LP; Margolick JB; Kaslow RA; O'Brien SJ; Mullins JI
    J Infect Dis; 2010 Feb; 201(4):618-26. PubMed ID: 20064070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection.
    van Manen D; Kootstra NA; Boeser-Nunnink B; Handulle MA; van't Wout AB; Schuitemaker H
    AIDS; 2009 Jan; 23(1):19-28. PubMed ID: 19050382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential prevalence of the HLA-C -- 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals.
    Ballana E; Ruiz-de Andres A; Mothe B; Ramirez de Arellano E; Aguilar F; Badia R; Grau E; Clotet B; del Val M; Brander C; Esté JA
    Immunobiology; 2012 Sep; 217(9):889-94. PubMed ID: 22333575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host Factor Predictors in Long-term Nonprogressors HIV-1 Infected with Distinct Viral Clades.
    Dos Santos JS; de Almeida SM; Ferreira GS; Bordignon J; Maia Teixeira SL; Martins Lima AC; Raboni SM
    Curr HIV Res; 2017; 15(6):440-447. PubMed ID: 29210660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV.
    Grabar S; Selinger-Leneman H; Abgrall S; Pialoux G; Weiss L; Costagliola D
    AIDS; 2009 Jun; 23(9):1163-9. PubMed ID: 19444075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of chemokine receptor polymorphisms With HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by antiretrovirals.
    Singh KK; Hughes MD; Chen J; Phiri K; Rousseau C; Kuhn L; Coutsoudis A; Jackson JB; Guay LA; Musoke P; Mmiro F; Semba RD; Spector SA
    J Acquir Immune Defic Syndr; 2008 Nov; 49(3):259-65. PubMed ID: 18845960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Considering genetic profiles in functional studies of immune responsiveness to HIV-1.
    Carrington M; Nelson G; O'Brien SJ
    Immunol Lett; 2001 Nov; 79(1-2):131-40. PubMed ID: 11595300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: a retrospective study.
    Jiménez-Sousa MÁ; Jiménez JL; Fernández-Rodríguez A; Bellón JM; Rodríguez C; Riera M; Portilla J; Castro Á; Muñoz-Fernández MÁ; Resino S
    J Biomed Sci; 2019 Oct; 26(1):83. PubMed ID: 31640710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects.
    Viladés C; Broch M; Plana M; Domingo P; Alonso-Villaverde C; Pedrol E; Knobel H; Dalmau D; Peraire J; Gutiérrez C; López A; Sambeat MA; Olona M; Garcia F; Richart C; Gatell JM; Vidal F;
    J Acquir Immune Defic Syndr; 2007 Feb; 44(2):132-8. PubMed ID: 17091019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses.
    Antoni S; Walz N; Landersz M; Humbert M; Seidl C; Dittmar MT; Dietrich U
    AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1377-86. PubMed ID: 18184081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphisms in the chemokine and chemokine receptors: impact on clinical course and therapy of the human immunodeficiency virus type 1 infection (HIV-1).
    Reiche EM; Bonametti AM; Voltarelli JC; Morimoto HK; Watanabe MA
    Curr Med Chem; 2007; 14(12):1325-34. PubMed ID: 17504215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.